These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18341479)

  • 21. Peptide-mediated delivery of nucleic acids into mammalian cells.
    Deshayes S; Simeoni F; Morris MC; Divita G; Heitz F
    Methods Mol Biol; 2007; 386():299-308. PubMed ID: 18604951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
    Morris MC; Depollier J; Mery J; Heitz F; Divita G
    Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion.
    Eiríksdóttir E; Konate K; Langel U; Divita G; Deshayes S
    Biochim Biophys Acta; 2010 Jun; 1798(6):1119-28. PubMed ID: 20214875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids.
    Maier MA; Esau CC; Siwkowski AM; Wancewicz EV; Albertshofer K; Kinberger GA; Kadaba NS; Watanabe T; Manoharan M; Bennett CF; Griffey RH; Swayze EE
    J Med Chem; 2006 Apr; 49(8):2534-42. PubMed ID: 16610796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the Mechanisms of Peptide-Mediated Delivery of Nucleic Acids Using Electron Microscopy.
    Margus H; Juks C; Pooga M
    Methods Mol Biol; 2015; 1324():149-62. PubMed ID: 26202268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
    Bolhassani A
    Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
    Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
    J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
    Wang F; Wang Y; Zhang X; Zhang W; Guo S; Jin F
    J Control Release; 2014 Jan; 174():126-36. PubMed ID: 24291335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling.
    Gerbal-Chaloin S; Gondeau C; Aldrian-Herrada G; Heitz F; Gauthier-Rouvière C; Divita G
    Biol Cell; 2007 Apr; 99(4):223-38. PubMed ID: 17233629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
    Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
    Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.